Company:  OPGEN INC (OPGN)
Form Type:  10-Q
Filing Date:  8/13/2021 
CIK:  0001293818 
Address:  9717 KEY WEST AVENUE
SUITE 100
 
City, State, Zip:  ROCKVILLE, Maryland 20850 
Telephone:  240-813-1260 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.50  
Change: 
-0.11 (-6.83%)  
Trade Time: 
01:43 PM EST  
Market Cap: 
$58.43M
Trade OPGN now with

© 2021  
Description of Business
Please refer to the Glossary at the end of this Business section for definitions or descriptions of scientific, diagnostic, healthcare, regulatory, and OpGen-specific terms used in this Annual Report. Overview OpGen, Inc. (the "Company") is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. The Company is developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. OpGen's proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections.
Register and access this filing in:     
  FORM 10-Q
    Part I. FINANCIAL INFORMATION
      Item 1. Unaudited Condensed Consolidated Financial Statements
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        Notes to Unaudited Condensed Consolidated Financial Statements
      Note 2 - Going Concern and Management's Plans
      FINANCIAL STATEMENTS
        CASH FLOW
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures
    Part II. OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 1A. Risk Factors
      Item 2. Unregistered Sales of Equity Securities and Use of ...
      Item 3. Defaults Upon Senior Securities
      Item 4. Mine Safety Disclosures
      Item 5. Other Information
      Item 6. Exhibits
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF CHIEF FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION